Grants Search Results

Based on progress to date, Dr. Wolfson was awarded a new grant in 2014 to fund an additional two years of this Scholar award. Cancer treatments for young children and older adults have made incredible progress. However, adolescents and young adults (AYAs) diagnosed at 15 to 39 years old have not seen these same improvements, leaving an AYA Gap. Within this AYA group, racial/ethnic minority patients fare poorly, as do patients not receiving care at a nationally recognized cancer center. This study tests the theory that the AYA Gap is largely due to disparities in access to quality cancer care. Ultimately, the aim of this project is to help develop strategies to reduce these disparities in outcome and eliminate the AYA Gap. Awarded at the City of Hope and transferred to University of Alabama at Birmingham.

This grant is for Pediatric Cancer Genomics (PGen), a research conference planned for February 2012. Attending will be leaders in national and international translational cancer genomics, to focus on pediatric solid tumors including neuroblastoma, medulloblastoma, Wilms tumor, osteosarcoma, Ewings sarcoma, rhabdomyosarcoma, and rare cancers striking adolescents and young adults. Topics will include next generation sequencing, functional genomics, translation, personalized molecularly directed therapy, biology, bioinformatics, and more. The meeting will be hosted by Translational Genomics Research Institute in Phoenix, Arizona and is being co-sponsored by the St. Baldrick's Foundation with the QuadW Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This grant funds a clinical research assistant to support the Late Effects/Survivorship program.

This grant funds a staff person to manage the Long-Term Survivor Clinic, providing comprehensive care including the enrollment of patients in long-term research studies.

This grant funds the development of a comprehensive long-term follow-up program to monitor and treat secondary cancers and the many other health issues that young cancer patients face as they enter into adulthood.

Intracranial Germ Cell Tumors (GCT) are rare brain tumors found mostly in teenagers, and their biology is poorly understood. We are generating the largest comprehensive genetic profiles of these tumors in collaboration with multiple institutions, to help us understand how these tumors arise and what determines their biological and clinical behavior. This may lead to new therapeutic targets. We will also develop a test that requires only small amount of tumor tissue to correctly sub-classify intracranial GCTs, and initiate the first-ever cell lines of these tumors for determining the impact of these genetic abnormalities and for preclinical drug screening.

Cancer affects every part of patients and their families' lives. Self-image, thinking clearly, anxiety, depression, social isolation and fear of recurrence are all problems that teens and young adults with cancer face, while resuming normal development and being monitored for many problems caused by cancer and its treatment. This research is to create developmentally sensitive information and make it available through touch-screen technology, connecting teens and young adults with their health care team and community resources in real-time. This helps identify, communicate and maximize the benefits of clinical care while helping them reintegrate into school and work.